Dona Ferentes
Pengurus pengatur
- Joined
- 11 January 2016
- Posts
- 16,252
- Reactions
- 22,187
I can just see it now, free cat scan with every $300 purchased.where to spend the money: quandary #76.
.
..Wesfarmers and ... Macquarie Group are the latest names to emerge as a keen competitors for the $3bn diagnostic imaging business I-MED that is about to hit the market.
It comes after Wesfarmers is understood to have carried out detailed analysis of the country’s largest diagnostic imaging provider I-MED as it keeps a keen focus on the healthcare industry for acquisitions.
WES recently appointed Kate Munnings as a director, the former boss of IVF provider Virtus Health and chief operating officer of Ramsay Healthcare...
.
from The Australian
I can just see it now, free cat scan with every $300 purchased.
Should work well.
Mick
A good boost to Bunnings bottom lineI can just see it now, free cat scan with every $300 purchased.
Should work well.
Mick
there are plenty of ways to scan a kit.I can just see it now, free cat scan with every $300 purchased
Mick
Missed the play on words the first time around.there are plenty of ways to scan a kit.
so, along comes another agenda-laden inquiry . from AFRWES Wesfarmers Ltd. My No 1 pick for the comp.
What can be said about this company that is going from strength to strength.
The SP seems to have no barrier as it continues its upward climb.
As usual, politicians never actually look at real data to back up their populist claptrap ideas.so, along comes another agenda-laden inquiry . from AFR
Bunnings faces grilling as Nats turn on ‘big-box’ retailers
Price-setting practices, land acquisitions and supplier relationships of major retail brands set to be scrutinised in a new Nationals-led Senate inquiry
Wesfarmers had Earnings Per Share (EPS) of 225.7 cents for FY2024 compared to 217.8 cents for FY2023. So that is a 3.6% increase in the past year roughly an increase in line with CPI. Meanwhile the stock is currently trading at $77.20 thats a p.e. ratio of 34 for a company that only grew its EPS by 3.6%. And there doesn't appear to be any rapid EPS growth projected for the next year or two either. Does anybody else think the valuation is crazy?
Wesfarmers full year sales gained 1.5 per cent to $44.2 billion, ahead of market expectations for 0.7 per cent gain
earnings before interest and tax rose 3.3 per cent to $4 billion.
Net profit was 3.7 per cent higher to $2.6 billion, inline with expectations.
yep.Does anybody else think the valuation is crazy?
I'd give it $50, but the growth isn't there to sustain anything more (based on sensible metrics)Honestly I think intrinsic value per share of Wesfarmers probably lies in the $35 - $45 per share range.
well i am not increasing the holding , except via the DRP ( where i participate )Wesfarmers had Earnings Per Share (EPS) of 225.7 cents for FY2024 compared to 217.8 cents for FY2023. So that is a 3.6% increase in the past year roughly an increase in line with CPI. Meanwhile the stock is currently trading at $77.20 thats a p.e. ratio of 34 for a company that only grew its EPS by 3.6%. And there doesn't appear to be any rapid EPS growth projected for the next year or two either. Does anybody else think the valuation is crazy?
Honestly I think intrinsic value per share of Wesfarmers probably lies in the $35 - $45 per share range.
The current share price is insane and like many mega cap stocks in Australia the share price and valuation is driven by passive ETF buying and large super funds passively index investing. CBA (Commonwealth Bank of Australia) is trading on a higher p.e. ratio than Alphabet (Google) in the U.S.A. which is insane.
I mean which individual investors or fund managers are actively buying Wesfarmers at todays price?
WES may well be overpriced in the view of some, but while the punters love this Magnificent WA once owned company the SP will keep tracking up.well i am not increasing the holding , except via the DRP ( where i participate )
over-valued , in my opinion,YES
so new buyers might be looking for 'growth ' that might come from the lithium exposure via the former Kidman Resources or via the health company acquisitions ( the former API and other small buys )
now i didn't spot the figure today , but WES still should have some cash left in the war-chest , and i didn't see ( yet ) a decision on the Office-Works question ( i am hoping for a REIT spin-off ala BWP )
remember the larger cap. stocks draw in cash from index funds automatically , and that can create a crazy cycle , super highs and breath-taking dips ( and index funds get some automatic cash injections from pension/super funds adding more momentum to the cycle )
my last buy of WES was @ $31.17 ( + brokerage ) AFTER the COL demerger in 2018 , and that is still roughly where i see good value for that stock
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?